Operational NoticeStore & dispatch paused Nov 15 โ€“ Dec 1 (warehouse expansion to accompany huge requests). Place festive orders before Nov 15!
๐Ÿช”Diwali Mega Deal๐Ÿ”ฅ Only 8 Bundles Available

Buy Ret3trutide 40mg at โ‚น14,600 โ†’ Get Klow Blend 80mg FREE (Worth โ‚น6,499)!

Back to all articles
Peptide Guides

TB-500 (Thymosin Beta-4): The Ultimate Healing Peptide for Injuries

TB-500 is the go-to peptide for systemic injury recovery. From muscle tears to cardiovascular repair, here's the mechanism, protocol, and what research shows.

8 min read10 November 2025

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring 43-amino acid peptide found in virtually every cell of the body. It plays a critical role in tissue repair, cell migration, and anti-inflammatory regulation. When injury occurs, Thymosin Beta-4 concentrations spike at the damage site โ€” TB-500 amplifies this natural response systemically.

Mechanism of Action

TB-500's primary mechanism is actin binding and sequestration. Actin is the protein that forms the cytoskeleton of cells โ€” it's essential for cell movement and repair. TB-500 binds to actin monomers, enabling cells to migrate into damaged tissue faster than normal.

  • Cell migration โ€” moves repair cells (fibroblasts, keratinocytes) to injury sites rapidly
  • Angiogenesis โ€” promotes new blood vessel formation feeding the repair zone
  • Anti-inflammatory โ€” downregulates inflammatory cytokines without suppressing the immune system
  • Stem cell activation โ€” activates progenitor cells in bone marrow and cardiac tissue

What Injuries Does TB-500 Help?

Musculoskeletal: Muscle tears, tendinopathy, ligament sprains, stress fractures. Particularly well-studied for chronic tendon injuries that haven't responded to conventional treatment.

Cardiovascular: Cardiac muscle repair post-injury. Studies show TB-500 promotes cardiac progenitor cell migration after myocardial infarction in animal models โ€” one of the few peptides with this property.

Skin: Wound healing, ulcers, corneal repair. TB-500 has been studied in human clinical trials for corneal wounds.

Neural: Emerging data on spinal cord injury and traumatic brain injury models showing neuroprotective effects.

Dosing Protocol

  • Loading phase (weeks 1โ€“6): 4โ€“5mg/week, split into 2โ€“2.5mg twice weekly
  • Maintenance phase (weeks 7+): 2โ€“2.5mg/week as single injection
  • Administration: Subcutaneous injection, any site
  • Frequency: Can be reduced to once every 2 weeks for maintenance

Stacking TB-500 with BPC-157

This is the most popular healing stack in peptide research for good reason. The two peptides work through complementary mechanisms:

  • BPC-157 โ€” local tissue repair, strong collagen synthesis stimulation, gut healing
  • TB-500 โ€” systemic cell migration, cardiovascular repair, anti-inflammatory at scale

Protocol: BPC-157 500mcg/day + TB-500 2.5mg twice weekly. Most users report noticeable improvement in chronic injuries within 2โ€“3 weeks.

Safety Profile

TB-500 has an excellent safety record across extensive animal research. Phase 1 human trials (for corneal wounds) showed no significant adverse effects. Does not suppress endocrine function. No known drug interactions. The main limitation is the limited human data โ€” most evidence is from animal models and anecdotal research use.

Related research products

TB-500thymosin beta-4peptide for injury healingTB-500 dosage